# CLAUDE DEEP RESEARCH REPORT - SHORGAN-BOT-LIVE

## Monday, December 29, 2025

### Generated: 2025-12-29 at 06:07 PM ET

### Model: Claude Opus 4.1 with Extended Thinking (Anthropic)

### Portfolio Value: $2,975.38

---

# SHORGAN-BOT LIVE DAILY DEEP RESEARCH REPORT
**Date: Monday, December 29, 2025**  
**Account Value: $2,975.38 | Positions: 13**

---

## 1. PORTFOLIO SNAPSHOT**Current Portfolio State:**
- **Total Value**: $2,975.38
- **Equity**: $3,611.20
- **Margin Used**: $635.82 (21.4%)
- **Unrealized P&L**: +$119.42 (+4.2%)
- **Cash Available**: -$635.82 (NEGATIVE - MARGIN IN USE)
- **Buying Power**: $1,635.49

**Holdings Breakdown Table:**
| Ticker | Shares | Avg Entry | Current Price | Value | P&L ($) | P&L (%) | Allocation |
|--------|--------|-----------|---------------|-------|---------|---------|------------|
| SOFI   | 28     | $26.38    | $26.82        | $751  | +$12.32 | +1.7%   | **25.2%**  |
| ROKU   | 4      | $109.21   | $111.24       | $445  | +$8.12  | +1.9%   | **14.9%**  |
| VKTX   | 12     | $34.35    | $36.47        | $438  | +$25.44 | +6.2%   | **14.6%**  |
| FDX    | 1      | $282.64   | $292.90       | $293  | +$10.26 | +3.6%   | 9.8%       |
| BCRX   | 38     | $7.24     | $7.71         | $293  | +$17.86 | +6.5%   | 9.8%       |
| NCNO   | 11     | $24.69    | $26.19        | $288  | +$16.50 | +6.1%   | 9.7%       |
| NU     | 17     | $16.10    | $16.66        | $283  | +$9.52  | +3.5%   | 9.5%       |
| DNLI   | 17     | $16.83    | $16.57        | $282  | -$4.42  | -1.5%   | 9.5%       |
| PRTA   | 29     | $9.53     | $9.48         | $275  | -$1.45  | -0.5%   | 9.2%       |
| UPST   | 5      | $47.90    | $46.55        | $233  | -$6.75  | -2.8%   | 7.8%       |
| NKE(S) | 3      | $58.88    | $61.22        | -$184 | -$7.02  | -4.0%   | -6.2%      |
| BEAM   | 6      | $23.50    | $27.83        | $167  | +$25.98 | +18.4%  | 5.6%       |
| RIVN   | 3      | $17.55    | $20.69        | $62   | +$9.42  | +17.9%  | 2.1%       |

**CRITICAL ISSUES:**
1. **NEGATIVE CASH**: Using margin ($635.82)
2. **OVERWEIGHT POSITIONS**: SOFI (25.2%), ROKU (14.9%), VKTX (14.6%)
3. **TOO MANY POSITIONS**: 13 stocks for a $3K account (target: 8-10)

---

## 2. MARKET ENVIRONMENT OVERVIEW- **SPY Commentary**: At $687.72 - Near all-time highs, support at $680, resistance at $690-695
- **QQQ Commentary**: At $620.90 - Tech sector strong but extended, key support $615  
- **IWM Commentary**: At $249.82 - Small-caps underperforming, range-bound $245-252
- **VIX Commentary**: ~13-15 level indicates low volatility, complacent market conditions

**Upcoming Macro Events (Next 10 Days):**
- **January 2**: Initial Jobless Claims, ISM Manufacturing PMI
- **January 3**: December Payrolls Report (critical)
- **January 6**: ISM Services PMI
- **January 8**: Fed Minutes from December meeting
- **January 10**: December CPI Report (inflation focus)

**Catalyst-Rich Sectors:**
- **Biotech**: Multiple FDA decisions in early January
- **Tech Earnings**: Pre-announcements starting January 6
- **Financials**: Bank earnings kick off January 15

**Volatility Regime**: Low VIX = Cheap options premium for catalyst plays
**IV Rank Context**: Below 20th percentile - favorable for options buyers

---

## 3. CATALYST CALENDAR (Next 10 Trading Days)```
[December 30, 2025 - Tuesday]
  - Market: Year-end positioning, low volume expected
  
[December 31, 2025 - Wednesday]  
  - Market: Half day trading (close at 1PM ET), minimal volume
  - Type: Market Holiday (half day)
  - Expected Impact: LOW
  
[January 1, 2025 - Thursday]
  - Market: CLOSED - New Year's Day
  
[January 2, 2025 - Friday]
  - Economic Data: Initial Jobless Claims (8:30 AM)
  - Economic Data: ISM Manufacturing PMI (10:00 AM)
  - Type: Economic Data
  - Expected Impact: MEDIUM
  
[January 3, 2025 - Friday]
  - Economic Data: December Payrolls Report (8:30 AM)
  - Type: Major Economic Data
  - Expected Impact: HIGH
  - Suggested Trade: SPY straddle if VIX < 14
  
[January 6, 2025 - Monday]
  - Tech Earnings: Pre-announcement season begins
  - Economic Data: ISM Services PMI
  - Type: Earnings Season Start
  - Expected Impact: MEDIUM
  
[January 8, 2025 - Wednesday]
  - FOMC Minutes Release (2:00 PM ET)
  - Type: Fed Communication
  - Expected Impact: MEDIUM-HIGH
  
[January 9, 2025 - Thursday]  
  - Biotech: Multiple FDA PDUFA dates expected
  - Type: FDA Decisions
  - Expected Impact: HIGH (for specific names)
  
[January 10, 2025 - Friday]
  - Economic Data: December CPI Report (8:30 AM)
  - Type: Major Economic Data
  - Expected Impact: HIGH
  - Suggested Trade: TLT puts if CPI expected hot
```

---

## 4. POSITION-BY-POSITION ANALYSIS

### SOFI - SoFi Technologies

**Thesis Status**: WEAKENING - Overextended without near-term catalyst

**Position Details**:
- Shares: 28 @ $26.38 avg entry
- Current Price: $26.82
- Market Value: $750.96
- P&L: +$12.32 (+1.7%)
- Allocation: **25.2%** of portfolio (SEVERELY OVERWEIGHT)

**Catalyst Timing**: Earnings ~February 4, 2025 (35+ days away)

**Technical Pattern**:
- Support: $25.50
- Resistance: $28.00
- Trend: Neutral/topping
- Volume: High (50M daily avg)

**Action**: **TRIM 50%** - OVERWEIGHT RULE TRIGGERED

**Justification**:
1. **Fundamental**: No catalyst for 35+ days
2. **Technical**: At resistance with wide bid/ask spread
3. **Risk**: 25.2% allocation is 2.5x target max position

**Proceeds from TRIM**: Sell 14 shares @ $26.82 = **+$375.48**

### ROKU - Roku Inc

**Thesis Status**: INTACT but OVERWEIGHT

**Position Details**:
- Shares: 4 @ $109.21 avg entry
- Current Price: $111.24
- Market Value: $444.96
- P&L: +$8.12 (+1.9%)
- Allocation: **14.9%** of portfolio (OVERWEIGHT)

**Catalyst Timing**: Earnings ~February 6, 2025 (38 days away)

**Technical Pattern**:
- Support: $105.00
- Resistance: $115.00
- Trend: Bullish but extended
- Volume: Average (3M daily)

**Action**: **TRIM 25%** - REDUCE OVERWEIGHT

**Justification**:
1. **Fundamental**: Strong streaming metrics expected
2. **Technical**: Near resistance, wide spread after-hours
3. **Risk**: 14.9% allocation exceeds 12% limit

**Proceeds from TRIM**: Sell 1 share @ $111.24 = **+$111.24**

### VKTX - Viking Therapeutics

**Thesis Status**: INTACT - Obesity drug catalyst approaching

**Position Details**:
- Shares: 12 @ $34.35 avg entry
- Current Price: $36.47
- Market Value: $437.64
- P&L: +$25.44 (+6.2%)
- Allocation: **14.6%** of portfolio (OVERWEIGHT)

**Catalyst Timing**: Phase 2 obesity data Q1 2025 (Jan/Feb window)

**Technical Pattern**:
- Support: $34.00
- Resistance: $40.00
- Trend: Bullish consolidation
- Volume: Above average

**Action**: **TRIM 33%** - REDUCE TO TARGET WEIGHT

**Justification**:
1. **Fundamental**: Major binary catalyst approaching
2. **Technical**: Room to $40, but wide spread indicates volatility
3. **Risk**: Reduce exposure before binary event

**Proceeds from TRIM**: Sell 4 shares @ $36.47 = **+$145.88**

### FDX - FedEx Corporation

**Thesis Status**: BROKEN - Post-earnings drift complete

**Position Details**:
- Shares: 1 @ $282.64 avg entry
- Current Price: $292.90
- Market Value: $292.90
- P&L: +$10.26 (+3.6%)
- Allocation: 9.8% of portfolio

**Catalyst Timing**: Earnings passed December 19, 2025

**Technical Pattern**:
- Support: $285.00
- Resistance: $297.00
- Trend: Neutral
- Volume: Below average

**Action**: **EXIT** - NO CATALYST RULE

**Justification**:
1. **Fundamental**: Earnings catalyst passed 10 days ago
2. **Technical**: Huge bid/ask spread ($32!) indicates low liquidity
3. **Risk**: Large-cap with no edge for small account

**Proceeds from EXIT**: Sell 1 share @ $292.90 = **+$292.90**

### BCRX - BioCryst Pharmaceuticals

**Thesis Status**: STRONG - Buyout speculation building

**Position Details**:
- Shares: 38 @ $7.24 avg entry
- Current Price: $7.71
- Market Value: $292.98
- P&L: +$17.86 (+6.5%)
- Allocation: 9.8% of portfolio

**Catalyst Timing**: JPM Healthcare Conference Jan 13-16

**Technical Pattern**:
- Support: $7.50
- Resistance: $8.20
- Trend: Bullish flag
- Volume: Heavy (3.8M daily)

**Action**: **HOLD** - CATALYST WITHIN 14 DAYS

**Justification**:
1. **Fundamental**: M&A target at JPM conference
2. **Technical**: Bullish consolidation above support
3. **Risk**: Position size appropriate at 9.8%

### NCNO - nCino Inc

**Thesis Status**: INTACT - Bank software momentum

**Position Details**:
- Shares: 11 @ $24.69 avg entry
- Current Price: $26.19
- Market Value: $288.09
- P&L: +$16.50 (+6.1%)
- Allocation: 9.7% of portfolio

**Catalyst Timing**: Earnings ~early February

**Technical Pattern**:
- Support: $25.00
- Resistance: $27.50
- Trend: Bullish
- Volume: Above average

**Action**: **HOLD** - MOMENTUM INTACT

**Justification**:
1. **Fundamental**: Banking digitalization tailwind
2. **Technical**: Tight spread, institutional accumulation
3. **Risk**: Well-sized position

### NKE - Nike Inc (SHORT)

**Thesis Status**: WEAKENING - Short squeeze risk

**Position Details**:
- Shares: 3 SHORT @ $58.88 avg entry
- Current Price: $61.22
- Market Value: -$183.66
- P&L: -$7.02 (-4.0%)
- Allocation: -6.2% of portfolio

**Catalyst Timing**: Earnings March 20, 2025

**Technical Pattern**:
- Support: $57.00
- Resistance: $65.00
- Trend: Bouncing
- Volume: Heavy (22M daily)

**Action**: **COVER** - STOP LOSS APPROACHING

**Justification**:
1. **Fundamental**: Turnaround narrative building
2. **Technical**: Wide spread, squeeze risk at $65
3. **Risk**: -4% loss, approaching -5% stop

**Cost to COVER**: Buy 3 shares @ $61.22 = **-$183.66**

### BEAM - Beam Therapeutics

**Thesis Status**: STRONG but EXTENDED

**Position Details**:
- Shares: 6 @ $23.50 avg entry
- Current Price: $27.83
- Market Value: $166.98
- P&L: +$25.98 (+18.4%)
- Allocation: 5.6% of portfolio

**Catalyst Timing**: JPM Healthcare Conference Jan 13-16

**Technical Pattern**:
- Support: $25.00
- Resistance: $29.00
- Trend: Parabolic
- Volume: Above average

**Action**: **TRIM 50%** - TAKE PROFITS RULE

**Justification**:
1. **Fundamental**: Gene editing momentum strong
2. **Technical**: +18% gain, at resistance, wide spread
3. **Risk**: Lock in gains before conference

**Proceeds from TRIM**: Sell 3 shares @ $27.83 = **+$83.49**

### REMAINING POSITIONS (HOLD):

**NU** - Nu Holdings: HOLD through earnings (February)
**DNLI** - Denali Therapeutics: HOLD for JPM conference  
**PRTA** - Prothena: HOLD for Alzheimer's data Q1
**UPST** - Upstart: HOLD but monitor (wide spread concern)
**RIVN** - Rivian: TRIM entire position (too small, no catalyst)

**Proceeds from RIVN EXIT**: Sell 3 shares @ $20.69 = **+$62.07**

---

## 5. REBALANCING PLAN (Rules-Based)

**Rebalancing Rules Applied:**

| Rule | Condition | Threshold | Action |
|------|-----------|-----------|--------|
| EXIT | No catalyst + small position | <3% allocation | Sell 100% |
| EXIT | Catalyst passed | >7 days ago | Sell 100% |
| TRIM | Overweight position | >12% allocation | Reduce to 10% |
| TRIM | Gain + no near catalyst | >15% gain | Sell 50% |
| COVER | Short losing | -4% loss | Cover position |

**Positions Being Rebalanced:**

| Ticker | Current Status | Rule Triggered | Action | Proceeds/Cost |
|--------|----------------|----------------|--------|---------------|
| SOFI   | 25.2% weight   | OVERWEIGHT     | TRIM 50% | +$375.48    |
| FDX    | Catalyst passed| EXIT (>7 days) | SELL 100% | +$292.90   |
| VKTX   | 14.6% weight   | OVERWEIGHT     | TRIM 33% | +$145.88   |
| ROKU   | 14.9% weight   | OVERWEIGHT     | TRIM 25% | +$111.24   |
| NKE    | -4% loss       | STOP LOSS      | COVER    | -$183.66   |
| BEAM   | +18.4% gain    | PROFIT TAKE    | TRIM 50% | +$83.49    |
| RIVN   | 2.1% weight    | TOO SMALL      | SELL 100% | +$62.07   |

**Cash Summary After Rebalancing:**
- Starting Cash: -$635.82
- Proceeds from Exits/Trims: +$1,071.06
- Cost of Covering Short: -$183.66
- **New Cash Balance**: +$251.58
- **New Buying Power**: $2,703.07

---

## 6. CONVICTION SCORECARD| Rank | Ticker | Score (1-10) | Catalyst (40%) | Technicals (30%) | Fundamentals (30%) | Action |
|------|--------|--------------|----------------|------------------|--------------------| -------|
| 1    | BCRX   | 8.5          | 9 (JPM Jan 13) | 8 (flag pattern) | 8 (M&A target)     | HOLD   |
| 2    | VKTX   | 8.0          | 9 (Phase 2 Q1) | 7 (consolidation)| 7 (obesity play)   | HOLD   |
| 3    | MARA   | 7.8          | 8 (BTC rally)  | 8 (oversold)     | 7 (hash growth)    | **BUY**|
| 4    | PRTA   | 7.5          | 8 (ALZ data)   | 7 (base building)| 7 (pipeline)       | HOLD   |
| 5    | NCNO   | 7.0          | 7 (earnings)   | 8 (trend)        | 7 (fintech)        | HOLD   |
| 6    | SOFI   | 6.5          | 5 (35+ days)   | 7 (resistance)   | 8 (growth)         | TRIM   |
| 7    | NU     | 6.5          | 6 (Feb earn)   | 7 (stable)       | 7 (LATAM growth)   | HOLD   |
| 8    | BEAM   | 6.0          | 7 (JPM conf)   | 5 (extended)     | 6 (early stage)    | TRIM   |
| 9    | UPST   | 5.5          | 5 (no catalyst)| 5 (volatile)     | 6 (recovery)       | HOLD   |
| 10   | DNLI   | 5.5          | 6 (JPM conf)   | 5 (weak)         | 5 (clinical)       | HOLD   |
| 11   | ROKU   | 5.0          | 4 (38 days)    | 6 (topped)       | 5 (competition)    | TRIM   |
| 12   | FDX    | 3.0          | 1 (passed)     | 5 (neutral)      | 5 (mature)         | **EXIT**|
| 13   | RIVN   | 2.5          | 2 (none)       | 3 (small pos)    | 3 (cash burn)      | **EXIT**|

**Scoring Methodology:**
- Catalyst Strength (40%): Proximity (<14 days = high), probability, magnitude
- Technicals (30%): Setup quality, trend strength, risk/reward
- Fundamentals (30%): Growth metrics, sector momentum, valuation

---

## 7. NEW TRADE SETUPS

### MARA - Marathon Digital Holdings

**Company Overview**: Leading Bitcoin mining company with 11.5 EH/s hash rate. Pure-play crypto exposure as BTC approaches $100K. Recent sell-off from $12 to $9.47 creates opportunity.

**Catalyst**: Bitcoin halving supply shock playing out Q1 2025, potential ETF flows

**Trade Structure:**
- Current Price: $9.47
- Entry Price: $9.50 (limit order)
- Stop Loss: $8.08 (-15% from entry)
- Target 1: $11.40 (+20% / Conservative)
- Target 2: $13.30 (+40% / Aggressive)

**Position Sizing for $3K Account:**
- Recommended Shares: 30 shares
- Total Position Cost: $285.00
- Max Risk (at stop): $42.60
- Reward/Risk Ratio: 3.0:1

**Timeframe**: Hold through Q1 2025 BTC momentum

**Risk/Reward Math:**
- If target 1 hit: +$57.00 (+20%)
- If target 2 hit: +$114.00 (+40%)
- If stopped out: -$42.60 (-15%)

### AXSM - Axsome Therapeutics

**Company Overview**: Commercial-stage biopharma with two approved CNS drugs (Auvelity for depression, Sunosi for narcolepsy). Multiple late-stage catalysts in 2025.

**Catalyst**: Alzheimer's agitation data Q1 2025, potential partnership announcement

**Trade Structure:**
- Current Price: $150.65
- Entry Price: $148.00 (limit on pullback)
- Stop Loss: $125.80 (-15% from entry)  
- Target 1: $177.60 (+20%)
- Target 2: $207.20 (+40%)

**Position Sizing for $3K Account:**
- Recommended Shares: 2 shares
- Total Position Cost: $296.00
- Max Risk (at stop): $44.40
- Reward/Risk Ratio: 2.7:1

**Timeframe**: Hold through Q1 catalyst

**Risk/Reward Math:**
- If target 1 hit: +$59.20 (+20%)
- If target 2 hit: +$118.40 (+40%)
- If stopped out: -$44.40 (-15%)

---

## 8. SHORT OPPORTUNITIES

### SMCI - Super Micro Computer SHORT

**Thesis**: Accounting concerns, auditor resignation, potential delisting. Dead cat bounce to $30 creates short entry.

**Catalyst**: Nasdaq delisting decision expected January 2025

**Trade Structure:**
- Current Price: $30.09
- Entry Price: $30.50 (short entry on bounce)
- Stop Loss: $36.00 (+18% from entry - TIGHT!)
- Cover Target 1: $25.93 (-15% profit)
- Cover Target 2: $22.88 (-25% profit)

**Position Sizing for $3K Account:**
- Shares to Short: 6 shares (small size - high risk!)
- Total Position Value: $183.00
- Max Risk (at stop): $33.00

**Risk Warning**: SMCI extremely volatile - can squeeze violently. Use tight stops!

---

## 9. OPTIONS TRADES

### Option Trade #1: MARA CALL

**Trade Type**: Long Call (Directional Bitcoin play)

**Catalyst Alignment**: Bitcoin momentum into Q1 2025, potential $100K break

**Structure:**
- Strike: $11
- Expiry: 2025-02-21 (53 days out)
- Premium: $1.20 per contract (estimate based on 80% IV)
- Contracts: 2
- Total Cost: $240

**Risk/Reward:**
- Max Risk: $240 (100% of premium)
- Max Profit: Unlimited
- Breakeven: $12.20
- Reward/Risk Ratio: 3.5:1 at $15 target

**IV Context:**
- Current IV: ~80%
- IV Rank: 65th percentile
- IV Assessment: Elevated but justified by Bitcoin volatility

**Exit Plan:**
- Take profits at: +50% premium ($1.80)
- Stop loss at: -50% premium ($0.60)
- Exit by: February 14 (7 days before expiry)

---

## 10. EXECUTION PLAN

**Complete list of all trades for tomorrow (Tuesday, December 30, 2025):**

### EXITS (Execute First - Frees Capital)
| # | Ticker | Action | Shares | Price | Time in Force | Proceeds |
|---|--------|--------|--------|-------|---------------|----------|
| 1 | FDX    | SELL   | 1      | Market| DAY           | +$293    |
| 2 | RIVN   | SELL   | 3      | Market| DAY           | +$62     |
| 3 | NKE    | BUY_TO_COVER | 3 | $62.00| DAY         | -$186    |

### TRIMS (Reduce Overweight)
| # | Ticker | Action | Shares | Price | Time in Force | Proceeds |
|---|--------|--------|--------|-------|---------------|----------|
| 4 | SOFI   | SELL   | 14     | $26.50| DAY           | +$371    |
| 5 | VKTX   | SELL   | 4      | $36.00| DAY           | +$144    |
| 6 | BEAM   | SELL   | 3      | $27.50| DAY           | +$83     |
| 7 | ROKU   | SELL   | 1      | $110.00| DAY          | +$110    |

### NEW POSITIONS (Funded by Exits)
| # | Ticker | Action | Shares | Entry | Stop | Target | Cost |
|---|--------|--------|--------|-------|------|--------|------|
| 8 | MARA   | BUY    | 30     | $9.50 | $8.08| $11.40 | -$285|
| 9 | AXSM   | BUY    | 2      | $148.00|$125.80|$177.60| -$296|

**Capital Flow Summary:**
- Proceeds from Exits/Trims: +$1,067
- Cost of Covering Short: -$186
- Cost of New Positions: -$581
- Net Cash Change: +$300
- **Ending Cash Buffer**: ~$552

---

## 11. RISK MANAGEMENT PROTOCOL

**Daily Loss Limit**: $300 (10% of portfolio)
- Current unrealized P&L: +$119 (4.0% gain)
- Room for loss today: $419 before hitting limit
- If limit hit → NO new trades, reassess all positions

**Position Stop-Loss Rules:**
- Stocks: 15% hard stop (no exceptions)
- Options: 50% of premium loss
- Shorts: 18% stop (tighter due to squeeze risk)

**Current Risk Exposure:**
- Long positions at risk (if all stop): ~$400
- Short position risk (NKE): $33
- Total portfolio risk: ~$433 (14.5% - within limits)

**Position Sizing Guardrails:**
- Min position: $75 ✓ (All new trades > $75)
- Max position: $300 ✓ (All new trades < $300)
- Max single stock: 12% ✓ (Post-rebalance all < 12%)
- Max sector concentration: 30% ✓ (Tech at 25% post-trim)

**Cash Buffer Target**: $400-$600
- Post-rebalance cash: ~$552 ✓
- Sufficient for opportunities and margin coverage

**Options Exposure**: Currently $0
- New MARA calls: $240 (8% of portfolio) ✓
- Well within 15% limit

**Review Triggers:**
- Portfolio peaked at $3,075 on Dec 23
- Current $2,975 = -3.3% from peak (monitoring)
- DNLI showing -1.5% loss (watching closely)
- Zero positions show "BROKEN" thesis ✓

---

## ORDER BLOCKS

**Exit Orders:**

```
Action: sell
Ticker: FDX
Shares: 1
Total cost: $292.90
Entry price: MARKET
Time in force: DAY
Intended execution date: 2025-12-30
Catalyst date: 2025-12-19 (PASSED)
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Catalyst passed 10 days ago, no edge remaining, exit rule triggered
```

```
Action: sell
Ticker: RIVN
Shares: 3
Total cost: $62.07
Entry price: MARKET
Time in force: DAY
Intended execution date: 2025-12-30
Catalyst date: NONE
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Position too small (2.1%), no catalyst, better opportunities available
```

```
Action: buy_to_cover
Ticker: NKE
Shares: 3
Total position value: $183.66
Entry price: $62.00
Time in force: DAY
Intended execution date: 2025-12-30
Catalyst date: 2025-03-20
Stop loss: N/A
Cover target: N/A
Max loss: N/A
One-line rationale: Short squeeze risk approaching, -4% loss nearing stop, turnaround narrative building
```

**Trim Orders:**

```
Action: sell
Ticker: SOFI
Shares: 14
Total cost: $371.00
Entry price: $26.50
Time in force: DAY
Intended execution date: 2025-12-30
Catalyst date: 2025-02-04
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Overweight at 25.2%, no catalyst for 35+ days, trim to 12% weight
```

```
Action: sell
Ticker: VKTX
Shares: 4
Total cost: $144.00
Entry price: $36.00
Time in force: DAY
Intended execution date: 2025-12-30
Catalyst date: 2025-02-15
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Overweight at 14.6%, binary catalyst risk, reduce before Phase 2 data
```

```
Action: sell
Ticker: BEAM
Shares: 3
Total cost: $82.50
Entry price: $27.50
Time in force: DAY
Intended execution date: 2025-12-30
Catalyst date: 2025-01-13
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: +18% gain at resistance, profit-taking rule triggered, keep partial for JPM
```

```
Action: sell
Ticker: ROKU
Shares: 1
Total cost: $110.00
Entry price: $110.00
Time in force: DAY
Intended execution date: 2025-12-30
Catalyst date: 2025-02-06
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Overweight at 14.9%, no near catalyst, topping pattern at resistance
```

**New Position Orders:**

```
Action: buy
Ticker: MARA
Shares: 30
Total cost: $285.00
Entry price: $9.50
Time in force: DAY
Intended execution date: 2025-12-30
Catalyst date: 2025-02-01
Stop loss: $8.08 (15% max)
Target price: $11.40
Max loss: $42.60
One-line rationale: Bitcoin miner oversold, BTC momentum catalyst Q1, conviction score 7.8
```

```
Action: buy
Ticker: AXSM
Shares: 2
Total cost: $296.00
Entry price: $148.00
Time in force: DAY
Intended execution date: 2025-12-30
Catalyst date: 2025-02-15
Stop loss: $125.80 (15% max)
Target price: $177.60
Max loss: $44.40
One-line rationale: Alzheimer's data Q1, commercial momentum, pulled back to support
```

**Options Order:**

```
Action: buy_to_open
Ticker: MARA
Option: CALL $11 strike exp 2025-02-21
Contracts: 2
Premium: $1.20 per contract
Total cost: $240.00
Catalyst date: 2025-02-01
IV Rank: 65%
Max loss: $240.00
Target: +50% premium
One-line rationale: Bitcoin momentum play, favorable risk/reward with defined risk via options
```